BNP Paribas Asset Management
SAGE

BNP Paribas Asset Management’s Sage Therapeutics SAGE Stock Holding History

BNP Paribas Asset Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-187,284
Closed -$13.5M – 822
2019
Q4 		$13.5M Buy
187,284
+125,534
+203% +$15.4M 0.09% 263
2019
Q3 		$8.66M Sell
61,750
-38,789
-39% -$6.49M 0.07% 325
2019
Q2 		$18.4M Sell
100,539
-26,274
-21% -$4.48M 0.15% 185
2019
Q1 		$20.2M Buy
126,813
+2,984
+2% +$432K 0.17% 171
2018
Q4 		$11M Buy
123,829
+35,244
+40% +$4.03M 0.1% 273
2018
Q3 		$12.5M Buy
88,585
+14,486
+20% +$2.24M 0.1% 287
2018
Q2 		$11.6M Buy
+74,099
New +$11.6M 0.1% 303

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BNP Paribas Asset Management's SAGE Position: Q1 2020 in Review

BNP Paribas Asset Management sold out of Sage Therapeutics (SAGE) in Q1 2020, closing a stake of 187,284 shares — an estimated $13.5M sold.

BNP Paribas Asset Management first reported a position in SAGE in Q2 2018 and held it in 7 quarters. The position peaked at $20.2M in Q1 2019. 230 funds tracked by Wall St. Rank hold SAGE as of Q1 2020.

  • BNP Paribas Asset Management reported no remaining Sage Therapeutics position as of Q1 2020 after selling out during the quarter.
  • BNP Paribas Asset Management sold 187,284 Sage Therapeutics shares in Q1 2020, an estimated $13.5M.
  • BNP Paribas Asset Management first reported a position in Sage Therapeutics in Q2 2018 and held it in 7 quarters.
  • BNP Paribas Asset Management's Sage Therapeutics position peaked at $20.2M in Q1 2019.
  • 230 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2020.

Based on BNP Paribas Asset Management's 13F filing for Q1 2020, filed 12 May 2020.